In this regard, Yeh et al. showed that TREM2 variants, including AD-associated (R47H, R62H, and D87N) and NHD linked mutations (Y38C and T66M) reduce binding between TREM2 and its ligands. This evidence concerns the gene TREM2 and Alzheimer disease.